Garcia Palacios V, Morita I, Murota S
Department of Cellular Physiological Chemistry, Graduate School, Tokyo Medical and Dental University, Tokyo, Japan.
Prostaglandins Leukot Essent Fatty Acids. 2001 Oct;65(4):215-21. doi: 10.1054/plef.2001.0314.
Recent studies have demonstrated that bone marrow stromal cells can undergo adipogenesis or osteoblastogenesis in vivo, and in vitro, and that peroxisome proliferator-activated receptor gamma (PPAR gamma) plays a central role in the control of adipocyte differentiation. In the present study, we treated a murine stromal cell line (TMS-14) with a cocktail of dexamethasone, insulin and glucose (DIG cocktail), which caused the cells to convert to fat-laden cells with adipocyte-like morphology. We also exposed TMS-14 cells to DIG cocktail followed by 15-deoxy Delta(12,14)-prostaglandin J2 (15d-PGJ2), a ligand of PPAR gamma, interleukin- 11 (IL-11), 9-cis retinoic acid (9-cis RA) and vitamin K2. 15d-PGJ2 enhanced DIG cocktail-induced adipogenesis, whereas IL-11, 9-cis RA and vitamin K2 each inhibited adipogenesis induced by DIG cocktail. The gene expressions of four adipogenesis markers, PPAR gamma 2, adipocyte P2 (aP2), adipocyte determination and differentiation factor 1 (ADD1), and fatty acid synthase (FAS) were enhanced by DIG cocktail and these expressions were more enhanced by 15d-PGJ2, in contrast they were attenuated by 9-cis RA. IL-11 also attenuated the adipogenesis markers except ADD1. Western blotting showed that 15d-PGJ2 enhanced the levels of PPAR gamma, C/EBP alpha and RXR alpha proteins, while IL-11 and 9-cis RA decreased the level of PPAR gamma protein, but not C/EBP alpha protein and vitamin K2 decreased the level of C/EBP alpha protein. We also tested the effect of 15d-PGJ2 on osteoblastogenesis, using TMS-12 cells, another stromal cell clone from the same mouse, which differentiate into osteoblasts spontaneously. 15d-PGJ2 did not affect osteoblastogenesis, as detected by von Kossa staining and Cbfa-1 gene expression. These data indicate that 15d-PGJ2 enhances the expression of both PPAR gamma and C/EBP alpha and as a result it stimulates adipogenesis in murine bone marrow cells.
近期研究表明,骨髓基质细胞在体内和体外均可发生脂肪生成或成骨细胞生成,且过氧化物酶体增殖物激活受体γ(PPARγ)在脂肪细胞分化的调控中起核心作用。在本研究中,我们用含有地塞米松、胰岛素和葡萄糖的混合液(DIG混合液)处理小鼠基质细胞系(TMS-14),这使得细胞转变为具有脂肪细胞样形态的充满脂肪的细胞。我们还将TMS-14细胞暴露于DIG混合液,随后再给予15-脱氧Δ(12,14)-前列腺素J2(15d-PGJ2)、白细胞介素-11(IL-11)、9-顺式视黄酸(9-cis RA)和维生素K2,其中15d-PGJ2是PPARγ的配体。15d-PGJ2增强了DIG混合液诱导的脂肪生成,而IL-11、9-cis RA和维生素K2均抑制了DIG混合液诱导的脂肪生成。DIG混合液增强了四种脂肪生成标志物PPARγ2、脂肪细胞P2(aP2)、脂肪细胞决定和分化因子1(ADD1)以及脂肪酸合酶(FAS)的基因表达,15d-PGJ2进一步增强了这些表达,相反,9-cis RA使其减弱。IL-11也减弱了除ADD1外的脂肪生成标志物的表达。蛋白质印迹分析表明,15d-PGJ2增强了PPARγ、C/EBPα和RXRα蛋白的水平,而IL-11和9-cis RA降低了PPARγ蛋白的水平,但未降低C/EBPα蛋白的水平,维生素K2降低了C/EBPα蛋白的水平。我们还使用TMS-12细胞(来自同一只小鼠的另一种基质细胞克隆,可自发分化为成骨细胞)测试了15d-PGJ2对成骨细胞生成的影响。通过冯·科萨染色和Cbfa-1基因表达检测发现,15d-PGJ2对成骨细胞生成没有影响。这些数据表明,15d-PGJ2增强了PPARγ和C/EBPα的表达,因此它刺激了小鼠骨髓细胞中的脂肪生成。